A detailed history of Hourglass Capital, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Hourglass Capital, LLC holds 15,840 shares of NVO stock, worth $2.08 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
15,840
Previous 15,140 4.62%
Holding current value
$2.08 Million
Previous $1.57 Million 29.82%
% of portfolio
0.61%
Previous 0.5%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

BUY
$102.11 - $135.92 $71,477 - $95,143
700 Added 4.62%
15,840 $2.03 Million
Q4 2023

Feb 09, 2024

BUY
$87.78 - $105.45 $140,448 - $168,720
1,600 Added 11.82%
15,140 $1.57 Million
Q3 2023

Nov 02, 2023

BUY
$90.94 - $199.54 $602,022 - $1.32 Million
6,620 Added 95.66%
13,540 $1.23 Million
Q2 2023

Aug 01, 2023

BUY
$155.98 - $172.65 $1.08 Million - $1.19 Million
6,920 New
6,920 $1.12 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $297B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Hourglass Capital, LLC Portfolio

Follow Hourglass Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hourglass Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hourglass Capital, LLC with notifications on news.